Your cells depend on the SLC24A1 gene when they need to clear calcium from the retina’s light sensing cells after light exposure. If this gene does not work properly, those cells do not reset normally, which can lead to trouble seeing in dim light, glare, and reduced visual sharpness. Pathogenic variants in both copies of the SLC24A1 gene are linked to congenital stationary night blindness, a lifelong eye condition that often starts early and usually changes little over time.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the cell’s working parts. Others mainly guide when certain activities happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. For a deeper look at this topic, you can find more in LearnHub.
Overview
SLC24A1Gene function
What if the gene works
The SLC24A1 gene helps light sensing cells in the retina reset after exposure to light. Its protein moves calcium out of these cells, which supports normal vision, especially in dim light.
Risk
What if the gene does not work
When the SLC24A1 gene does not work properly, it is best known for congenital stationary night blindness, with lifelong trouble seeing in dim light and reduced rod function on eye testing. Milder or more severe variants can change symptom strength.
Treatment
What does that mean for your treatment
No treatment or medication strategy is currently tailored specifically to pathogenic variants in the SLC24A1 gene.
Conditions associated with SLC24A1
Gene function
What if the gene works
In the retina, the SLC24A1 gene helps rod cells reset after they detect light. It does this by moving calcium in a controlled way across the cell membrane. When this system runs smoothly, rod cells stay ready to respond from one moment to the next, especially in dim settings.
The SLC24A1 gene helps rod cells move calcium out after light has been detected. This controlled calcium flow is a key part of how the retina responds to light and prepares for the next visual signal.
Its protein acts as a membrane transporter, trading calcium and potassium for sodium. This exchange uses normal salt differences across the cell surface to keep rod cell chemistry in balance.
As calcium levels return to their usual range, rod cells can recover from a flash and get ready to detect light again. This supports steady signaling, especially for vision in darker surroundings.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC24A1 gene often reduce how well the protein folds, reaches the cell surface, or moves calcium out of light sensing cells in the retina. This is why SLC24A1 gene variants linked to congenital stationary night blindness can differ in their impact: milder changes may leave some transport activity, while more severe variants can nearly abolish it. That functional range can influence how early visual symptoms appear and how marked night vision problems are.
How variants are linked to conditions
Pathogenic variants in the SLC24A1 gene are linked to autosomal recessive congenital stationary night blindness, an inherited eye condition that usually begins early in life. A person typically has this condition when both copies of the gene carry a pathogenic variant, so finding pathogenic variants in both copies can confirm the diagnosis. Among reported conditions, the clearest link between the SLC24A1 gene and congenital stationary night blindness is the one most consistently supported in human genetics.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC24A1 gene. If a disease-causing change is present, overall risk is usually driven mainly by that genetic change, and a doctor or genetic counselor can help explain what it means for you or your family.
Inheritance of SLC24A1 variants
The SLC24A1 inheritance pattern for the best-known related eye condition is autosomal recessive. This means a child usually inherits one SLC24A1 variant from each parent, and the parents are often healthy carriers. If both parents carry a variant in the SLC24A1 gene, each pregnancy has a 25% chance of the child having the condition, a 50% chance of the child being a carrier, and a 25% chance of inheriting neither variant. Sons and daughters are affected equally.
What does my SLC24A1 result mean for my family?
For SLC24A1, family impact is usually discussed in a recessive pattern, which means close relatives may be carriers even if they have no vision symptoms. Brothers and sisters could also have the condition or be carriers, and adult family members may wish to learn their carrier status if they are planning children. The main concern for relatives is usually night vision problems that can run quietly through a family.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the SLC24A1 gene, doctors use genetic testing for SLC24A1 variants on a saliva sample or blood sample. A lab reads the DNA sequence and checks for variants in this gene, then reports whether a variant was found and how it is classified.
When should I consider getting a genetic test?
Consider testing for the SLC24A1 gene if you or your child has lifelong trouble seeing in dim light or at night, especially if similar vision problems run in the family. A genetic test can help show whether an inherited change in this gene is the cause.
A genetic result is only one part of your health story
Genetic test results can offer meaningful insight, but what they tell you depends on the condition and the kind of variant involved. Over time, many other factors also shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, these results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more slowly, while another may process it faster or be more sensitive to its effects. These inherited differences are common and can influence how well a treatment works or the chance of side effects. Medication response also reflects other factors, including age, kidney and liver function, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape the way a person responds to medication. By looking at the relationship between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes affect how the body processes a drug and how strong its effects can be. This understanding can support treatment decisions that are both better informed and more individualized. More information on this topic is available in the LearnHub.
Drugs influenced by the SLC24A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how people respond to medicines. If you have concerns about side effects, how well a medicine is working, or possible interactions with your health condition, speak with your doctor or pharmacist.
History
SLC24A1 entered the genetics literature in the late 1990s, when researchers studying vision identified it as part of a newly recognized family of ion transport genes. Initially understood only through visible traits, later recognized as tied to a specific gene, its story reflects the broader shift from physiology to modern DNA-based research. Early work focused on its strong activity in the retina, which helped place it within pathways important for normal sight. From these first observations, research expanded steadily. In the years that followed, rare inherited SLC24A1 variants were linked to eye conditions including congenital stationary night blindness, giving the gene a clearer place in clinical genetics.